secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evelo Biosciences, Inc. (—)
CIK:        0001694665
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001694665-23-000034
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Evelo Biosciences receives Nasdaq deficiency notices for MVLS and MVPHS below thresholds
--------------------------------------------------------------------------------

- MVLS below $50M for 30 consecutive business days; compliance period ends Oct 23, 2023.
- MVPHS below $15M for 30 consecutive business days; compliance period ends Oct 25, 2023.
- Stock continues trading under EVLO while company monitors compliance and evaluates options.
- Company may appeal delisting or apply to transfer to Nasdaq Capital Market if non-compliant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000034/0001694665-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000034/evlo-20230425.htm
  HTML page:      https://secwatch.observer/filing/0001694665-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer